Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel Cancer Imaging.                    

*Date:*                         March 6, 2012.                    

*Time:*                         11 a.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 707, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Eun Ah Cho, Ph.D., Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Suite 703, Room 7073, Bethesda, MD 20892, 301-435-1822,                         *choe@mail.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to scheduling conflicts.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Behavioral Research in Cancer Control (R03).                    

*Date:*                         March 8, 2012.                    

*Time:*                         8:30 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.                    

*Contact Person:*                         Ellen K Schwartz, EDD, MBA, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8055B, Bethesda, MD 20892-8329, 301-594-1215,                         *schwarel@mail.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to scheduling conflicts.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Quantitative Imaging for Evaluation of Responses to Cancer Therapies.                    

*Date:*                         March 8, 2012.                    

*Time:*                         1 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 707, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Gerald G. Lovinger, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8101, Bethesda, MD 20892-8329, 301/496-7987,                         *lovingeg@mail.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to scheduling conflicts.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; SBIR Phase IIB Bridge Awards.                    

*Date:*                         March 20, 2012.                    

*Time:*                         11 a.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6116 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Savvas C Makrides, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., RM 8050a, Bethesda,                               ( print page 12601)                            MD 20892, 301-496-7421,                         *makridessc@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Pre-Clinical Pharmacology and Toxicology Studies.                    

*Date:*                         March 20, 2012.                    

*Time:*                         12 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 210, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Lalita D. Palekar, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7141, Bethesda, MD 20892, 301-496-7575,                         *palekarl@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Provocative Questions R01.                    

*Date:*                         March 26-27, 2012.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877.                    

*Contact Person:*                         Kenneth L. Bielat, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7147, Bethesda, MD 20892-8329, 301-496-7576,                         *bielatk@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Provocative Questions R21.                    

*Date:*                         March 28-29, 2012.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877.                    

*Contact Person:*                         Joyce C. Pegues, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, NIH National Cancer Institute, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892-8329, 301-594-1286,                         *peguesj@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Development of Anti-Cancer Agents.                    

*Date:*                         March 29-30, 2012.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.                    

*Contact Person:*                         Savvas C. Makrides, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8050a, Bethesda, MD 20892, 301-496-7421,                         *makridessc@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; R13 Review.                    

*Date:*                         April 11, 2012.                    

*Time:*                         1 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 8041, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Bratin K. Saha, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8041, Bethesda, MD 20892, 301-402-0371,                         *sahab@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Cancer Research Infrastructure Support for HMOs.                    

*Date:*                         April 18, 2012.                    

*Time:*                         1 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 8055B, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Ellen K. Schwartz, EDD, MBA, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8055B, Bethesda, MD 20892-8329, 301-594-1215,                         *schwarel@mail.nih.gov.*

                        Information is also available on the Institute's/Center's home page:                         *http://deainfo.nci.nih.gov/​advisory/​sep/​sep.htm,*                         where an agenda and any additional information for the meeting will be posted when available.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: February 22, 2012.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2012-4922 Filed 2-29-12; 8:45 am]

BILLING CODE 4140-01-P